{"id":196799,"date":"2025-11-24T00:36:08","date_gmt":"2025-11-24T00:36:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/196799\/"},"modified":"2025-11-24T00:36:08","modified_gmt":"2025-11-24T00:36:08","slug":"fusobacterium-nucleatum-reprogrammed-adipocytes-promote-tumor-cisplatin-resistance-through-the-ccl2-ccr2-axis-in-the-necrotic-metastatic-neck-nodes-of-head-and-neck-carcinoma-cell-communication-and","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/196799\/","title":{"rendered":"Fusobacterium nucleatum-reprogrammed adipocytes promote tumor cisplatin resistance through the CCL2-CCR2 axis in the necrotic metastatic neck nodes of head and neck carcinoma | Cell Communication and Signaling"},"content":{"rendered":"
  • \n

    Hanai N, Ozawa T, Hirakawa H, et al. The nodal response to chemoselection predicts the risk of recurrence following definitive chemoradiotherapy for pharyngeal cancer [J]. Acta Otolaryngol. 2014;134(8):865\u201371.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wolf G T, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation [J]. Laryngoscope. 1992;102(8):934\u20139.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liauw SL, Amdur RJ, Morris CG, et al. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck [J]. Head Neck. 2007;29(8):715\u20139.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Li F, Hsueh C, Huang H, et al. A nomogram to predict nodal response after induction chemotherapy for hypopharyngeal carcinoma [J]. Laryngoscope. 2022; 133(4):849\u201355<\/p>\n<\/li>\n

  • \n

    Huang CK, Chang PH, Kuo WH, et al. Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via \u03b2-hydroxybutyrate [J]. Nat Commun. 2017;8:14706.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Takehara M, Sato Y, Kimura T, et al. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression [J]. Cancer Sci. 2020;111(8):2883\u201394.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hu W, Ru Z, Zhou Y, et al. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway [J]. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(8):1091\u2013102.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth [J]. Nat Med. 2011;17(11):1498\u2013503.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    He JY, Wei XH, Li SJ, et al. Adipocyte-derived IL-6 and leptin promote breast cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression [J]. Cell Commun Signal. 2018;16(1):100.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Zhang Q, Deng T, Zhang H et al. Adipocyte-Derived Exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer [J]. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2022;9(28):e2203357.<\/p>\n<\/li>\n

  • \n

    Li K, Bihan M, Yooseph S, et al. Analyses of the microbial diversity across the human Microbiome [J]. PLoS ONE. 2012;7(6):e32118.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Gong HL, Shi Y, Zhou L, et al. The composition of Microbiome in larynx and the throat biodiversity between laryngeal squamous cell carcinoma patients and control population [J]. PLoS ONE. 2013;8(6):e66476.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Gong H, Shi Y, Zhou X, et al. Microbiota in the throat and risk factors for laryngeal carcinoma [J]. Appl Environ Microbiol. 2014;80(23):7356\u201363.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hsueh CY, Gong H, Cong N, et al. Throat microbial community structure and functional changes in postsurgery laryngeal carcinoma patients [J]. Appl Environ Microbiol. 2020;86(24):e01849\u201320.<\/p>\n<\/li>\n

  • \n

    Gong H, Shi Y, XiaO X, et al. Alterations of microbiota structure in the larynx relevant to laryngeal carcinoma [J]. Sci Rep. 2017;7(1):5507.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hsueh C Y, Huang Q, Gong H, et al. A positive feed-forward loop between Fusobacterium nucleatum and ethanol metabolism reprogramming drives laryngeal cancer progression and metastasis [J]. iScience. 2022;25(2):103829.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hsueh CY, Lau HC, Huang Q, et al. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck [J]. Cancer. 2022;128(17):3170\u201384.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Park HR, Ju EJ, Jo SK, et al. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice [J]. BMC Cancer. 2009;9:85.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yang F, Yuan C, Chen F, et al. Combined IL6 and CCR2 Blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer [J]. J Exp Clin Cancer Res. 2024;43(1):76.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yu J, Chen Y, Fu X, et al. Invasive Fusobacterium nucleatum May play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway [J]. Int J Cancer. 2016;139(6):1318\u201326.<\/p>\n<\/li>\n

  • \n

    Furukawa N, Ongusaha P, Jahng WJ, et al. Role of Rho-kinase in regulation of insulin action and glucose homeostasis [J]. Cell Metab. 2005;2(2):119\u201329.<\/p>\n<\/li>\n

  • \n

    Fontana F, Anselmi M. Carollo E, Adipocyte-Derived extracellular vesicles promote prostate cancer cell aggressiveness by enabling multiple phenotypic and metabolic changes [J]. Cells. 2022;11(15):2388.<\/p>\n<\/li>\n

  • \n

    Maguire OA, Ackerman SE, Szwed SK, et al. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer [J]. Cell Metab. 2021;33(3):499\u2013e5126.<\/p>\n<\/li>\n

  • \n

    Newman NK, Zhang Y, Padiadpu J, et al. Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome [J]. Microbiome. 2023;11(1):208.<\/p>\n<\/li>\n

  • \n

    Cani PD, Van Hul M. Gut microbiota in overweight and obesity: crosstalk with adipose tissue [J]. Nat Rev Gastroenterol Hepatol. 2024;21(3):164\u201383.<\/p>\n<\/li>\n

  • \n

    Cani PD. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue [J]. Clin Microbiol Infect. 2012;18(Suppl 4):50\u20133.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yamaguchi M, Nishimura F, Naruishi H, et al. Thiazolidinedione (pioglitazone) blocks P. gingivalis- and F. nucleatum, but not E. coli, lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) production in adipocytes [J]. J Dent Res. 2005;84(3):240\u20134.<\/p>\n<\/li>\n

  • \n

    Liu SC, Tsang NM Leepj, et al. Epstein-Barr virus induces adipocyte dedifferentiation to modulate the tumor microenvironment [J]. Cancer Res. 2021;81(12):3283\u201394.<\/p>\n<\/li>\n

  • \n

    Planellas P, Cornejo L, Farr\u00e9s R et al. Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study [J]. BJS Open. 2022;6(2):zrac009.<\/p>\n<\/li>\n

  • \n

    Chua DT, Sham JS, Kwong DL, et al. Evaluation of cervical nodal necrosis in nasopharyngeal carcinoma by computed tomography: incidence and prognostic significance [J]. Head Neck. 1997;19(4):266\u201375.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liang SB, Chen LS, Yang XL, et al. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma [J]. Radiother Oncol. 2021;155:219\u201325.<\/p>\n<\/li>\n

  • \n

    Fu JY, Yue XH, Dong M J, et al. Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer [J]. Cancer Med. 2023;12(3):2417\u201326.<\/p>\n<\/li>\n

  • \n

    Jiang Y, Liang Z, Chen K, et al. A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma [J]. Eur Radiol. 2023;33(3):2171\u201384.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Zapletal E, Vasiljevic T, Busson P et al. Dialog beyond the grave: necrosis in the tumor microenvironment and its contribution to tumor growth [J]. Int J Mol Sci. 2023;24(6):5278.<\/p>\n<\/li>\n

  • \n

    Karsch-Bluman A, Feiglin A, Arbib E, et al. Tissue necrosis and its role in cancer progression [J]. Oncogene. 2019;38(11):1920\u201335.<\/p>\n<\/li>\n

  • \n

    Rajasekaran K, Carey RM, Lin X, et al. The Microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis [J]. Oral Oncol. 2021;117:105305.<\/p>\n<\/li>\n

  • \n

    Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer [J]. Cell. 2022;185(8):1356\u2013e7226.<\/p>\n<\/li>\n

  • \n

    Iwamoto H, Izumi K, Nakagawa R et al. Serum CCL2 is a prognostic biomarker for Non-Metastatic Castration-Sensitive prostate cancer [J]. Biomedicines. 2022;10(10):2369.<\/p>\n<\/li>\n

  • \n

    Dong Y, Zhang S, ZHAO S, et al. CCL2 promotes lymphatic metastasis via activating RhoA and Rac1 pathway and predict prognosis to some extent in tongue cancer [J]. Cancer Biol Ther. 2023;24(1):2205342.<\/p>\n<\/li>\n

  • \n

    Qian Y, DING P, Xu J, et al. CCL2 activates AKT signaling to promote Glycolysis and chemoresistance in glioma cells [J]. Cell Biol Int. 2022;46(5):819\u201328.<\/p>\n<\/li>\n

  • \n

    Sun W, Wang X, Wang D et al. CD40\u00d7HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer [J]. J Immunother Cancer. 2022;10(7):e005063.<\/p>\n<\/li>\n

  • \n

    Yang H, Zhang Q, Xu M, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis [J]. Mol Cancer. 2020;19(1):41.<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nywening TM, Wang-Gillam A, Sanford D E, et al. Targeting tumour-associated macrophages with CCR2 Inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial [J]. Lancet Oncol. 2016;17(5):651\u201362.<\/p>\n<\/li>\n

  • \n

    Pervushin NV, Yapryntseva MA, Panteleev MA, et al. Cisplatin resistance and metabolism: simplification of complexity [J]. Cancers (Basel). 2024;16(17):3082.<\/p>\n<\/li>\n

  • \n

    Guo J, Satoh K, Tabata S, et al. Reprogramming of glutamine metabolism via glutamine synthetase Silencing induces cisplatin resistance in A2780 ovarian cancer cells [J]. BMC Cancer. 2021;21(1):174.<\/p>\n<\/li>\n

  • \n

    Liu WJ, Pan PY, Sun Y, et al. Deferoxamine counteracts cisplatin resistance in A549 lung adenocarcinoma cells by increasing vulnerability to glutamine Deprivation-Induced cell death [J]. Front Oncol. 2021;11:794735.<\/p>\n<\/li>\n

  • \n

    Shen X, Wang G, He H, et al. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer [J]. Breast Cancer (Tokyo Japan). 2024;31(1):96\u2013104.<\/p>\n<\/li>\n","protected":false},"excerpt":{"rendered":"Hanai N, Ozawa T, Hirakawa H, et al. The nodal response to chemoselection predicts the risk of recurrence…\n","protected":false},"author":2,"featured_media":196800,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[78],"tags":[109329,109331,7580,42068,108501,18,109330,109332,135,19,17,108499,108500],"class_list":{"0":"post-196799","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-adipocyte","9":"tag-ccl2","10":"tag-cell-biology","11":"tag-cisplatin","12":"tag-cytokines-and-growth-factors","13":"tag-eire","14":"tag-fusobacterium-nucleatum","15":"tag-head-and-neck-carcinoma","16":"tag-health","17":"tag-ie","18":"tag-ireland","19":"tag-protein-ligand-interactions","20":"tag-receptors"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115601878900571606","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/196799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=196799"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/196799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/196800"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=196799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=196799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=196799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}